Eton Pharmaceuticals (ETON) Non-cash Items (2017 - 2025)

Eton Pharmaceuticals has disclosed Non-cash Items across 9 years of filings, most recently posting $4.7 million for Q4 2025.

• Non-cash Items for Q4 2025 came in at $4.7 million, up 15.84% year-over-year; the trailing twelve-month figure through Dec 2025 was $4.7 million (up 15.84% YoY), and the FY2025 annual result was $4.7 million, up 15.84% from the prior year.
• Non-cash Items came in at $4.7 million for Q4 2025 at Eton Pharmaceuticals, down from $97.8 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $97.8 million in Q3 2025 to a low of $682000.0 in Q3 2021.
• The 5-year median for Non-cash Items is $3.6 million (2024), against an average of $8.4 million.
• Across the five-year window, Non-cash Items slumped 94.07% in 2021 and jumped 2307.8% in 2025, its largest moves.
• Eton Pharmaceuticals' Non-cash Items stood at $2.7 million in 2021, then advanced by 2.9% to $2.8 million in 2022, then climbed by 29.09% to $3.6 million in 2023, then advanced by 12.31% to $4.0 million in 2024, then advanced by 15.84% to $4.7 million in 2025.
• The last three Non-cash Items figures came in at $4.7 million (Q4 2025), $97.8 million (Q3 2025), and $4.4 million (Q2 2025), per Business Quant data.